Daqing Oilfield General Hospital

Running trials

• Recruiting

  Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

  NCT07567625· Source

• Recruiting

  A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

  NCT07509892· Phase 2· Source

• Not yet recruiting

  Ongericimab Injection Reducing Recurrence of Ischemic Stroke

  NCT07242599· Phase 3· Source

• Recruiting

  Phase II Trial of RC1416 Injection in Asthma

  NCT07403487· Phase 2· Source

• Recruiting

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· Phase 3· Source

• Recruiting

  A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

  NCT07520565· Phase 3· Source

• Recruiting

  Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

  NCT07279493· Phase 2· Source

• Recruiting

  Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

  NCT07110415· Phase 4· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Source

• Recruiting

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· Phase 3· Source

• Recruiting

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  NCT06424288· Phase 3· Source

• Recruiting

  Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

  NCT06365502· Source

• Recruiting

  Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction

  NCT05410925· Phase 4· Source

• Recruiting

  Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

  NCT05686642· Phase 2· Source

• Active, not recruiting

  Sympathetic Mapping/ Ablation of Renal Nerves Trial

  NCT02761811· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke5 recruiting
• Coronary artery disease4 recruiting
• Heart failure2 recruiting
• Asthma1 recruiting
• IgA nephropathy1 recruiting
• Lupus (SLE)1 recruiting
• Obesity1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

  NCT06068465· Phase 3· Source

• Completed

  Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

  NCT06429384· Phase 2· Source

• Completed

  Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

  NCT05949801· Phase 3· Source

• Completed

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· Phase 3· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Source